Aescap logo

Investing in People and Medicine that Make a Difference

Performance Aescap 2.0 at 31-07-18

Gross performance:
(net of fees but including fund costs)

Year 2 Year 1 Run-in period: 2014 + 2015*
10% 27% 133%

*The fund manager’s performance in the 2-year run-in period

Net Performance (since start at March 28, 2016):

Since Start 2018 1 month 3 months 6 months
55,2% 32,1% 5,0% 18,9% 13,3%

Net Asset Value per:

31-07-2018: €1.551,97
30-06-2018: €1.477,84
31-05-2018: €1.459,63
30-04-2018: €1.305,78
31-03-2018: €1.266,38
28-02-2018: €1.331,38
31-01-2018: €1.370,09
31-12-2017: €1.174,42
30-11-2017: €1.180,52
31-10-2017: €1.295,50
30-09-2017: €1.296,47
31-08-2017: €1.197,59
31-07-2017: €1.216,42
30-06-2017: €1.212,36
31-05-2017: €1.172,14
30-04-2017: €1.189,34
31-03-2017: €1.194,68
28-02-2017: €1.143,87
31-01-2017: €1.071,40
31-12-2016: €1.122,05
30-11-2016: €1.066,79
31-10-2016: €1.024,22
30-09-2016: €1.113,74
31-08-2016: €1.111,97
31-07-2016: €1.081,13
30-06-2016: €1.029,64
31-05-2016: €1.119,95
30-04-2016: €1.032,99
31-03-2016: €1.009,12

Net Asset Value at the start of the fund (28-03-2016): €1.000,00